Elaine D. Crowley, a director of D.R. Horton, reported the conversion of restricted stock units into common shares on 08/26/2025. A tranche of 264 restricted stock units converted into 264 shares of DHI common stock at no cash price, increasing her directly held shares by 264 to reflect the vested portion. Following this transaction she beneficially owns 1,056 restricted stock units that remain unvested. The RSUs were originally granted on 08/26/2024 as 1,320 units vesting in five annual installments beginning 08/26/2025. The Form 4 was signed by an attorney-in-fact.
Crow M. Chad, a director of D.R. Horton, Inc. (DHI), reported transactions dated 08/26/2025. The filing shows 264 restricted stock units vested and were converted into 264 shares of common stock under a previously granted award. After the conversion, the reporting person beneficially owned 398 shares of DHI common stock for non-derivative holdings and 1,056 derivative securities (restricted stock units) following the reported derivative transaction. The RSU grant referenced in the explanation totaled 1,320 restricted stock units awarded on 08/26/2024, vesting in five annual installments beginning 08/26/2025.
Aron M. Odom, SVP, Controller and PAO of D.R. Horton, reported an insider sale. On 08/13/2025 he sold 1,233 shares of DHI at $166.20 per share and retained 7,833 shares after the transaction. The filing is a Form 4 reporting an individual transaction and is signed 08/14/2025.
The filing notifies a proposed sale of 1,233 shares of D.R. Horton common stock through Charles Schwab & Co., Inc. on 08/13/2025 on the NYSE, with an aggregate market value of $204,925.00 and 298,123,529 shares outstanding. The shares were acquired as restricted stock lapses from D.R. Horton, Inc.: 970 shares on 03/12/2025 and 263 shares on 03/21/2025, with payment described as Equity Compensation. The form reports Nothing to Report for sales in the past three months. Certain administrative fields such as filer identification and the date of notice appear blank on the form.
A Form 144 filing by D.R. Horton indicates a proposed sale of 2,150 shares of common stock with an aggregate market value of $274,552. The sale is planned to be executed through Charles Schwab & Co. on the NYSE, with an approximate sale date of June 24, 2025.
The shares to be sold were acquired through multiple restricted stock lapses:
- 254 shares on 11/26/2022
- 470 shares on 11/26/2023
- 763 shares on 01/26/2024
- 663 shares on 01/26/2025
All shares were received as equity compensation from the company. The total outstanding shares of D.R. Horton common stock are 307,181,294. No other securities were reported as sold by the filer during the past 3 months.
Form 4 alert: D.R. Horton, Inc. (DHI) director Michael R. Buchanan disclosed the sale of 2,150 common shares on 24 Jun 2025 at a weighted-average price of $127.6988, generating proceeds of roughly $274k. The transaction was coded “S,” indicating an open-market sale rather than option exercise or other derivative activity. After the trade, Buchanan’s direct ownership falls to 2,193 shares, while he continues to hold 8,136 shares indirectly through his spouse, for a combined beneficial position of 10,329 shares.
The filing notes that the price range for the sale was $127.53–$127.895; detailed breakdowns are available on request. No derivative transactions were reported, and the filing does not reference a Rule 10b5-1 trading plan.
Relative impact: the disposed shares represent roughly 49% of Buchanan’s direct stake but are immaterial versus DHI’s ~357 million shares outstanding. Insider sales can signal limited near-term enthusiasm, yet a single, modest-sized sale—worth <0.01% of daily trading volume—typically carries limited market significance. Investors may monitor future filings for any pattern of continued selling.